Charles Schwab’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,120
| Closed | -$71K | – | 3545 |
|
|
2021
Q2 | $71K | Sell |
1,120
-4,380
| -80% | -$278K | ﹤0.01% | 3325 |
|
|
2021
Q1 | $678K | Buy |
5,500
+534
| +11% | +$65.8K | ﹤0.01% | 2977 |
|
|
2020
Q4 | $565K | Hold |
4,966
| – | – | ﹤0.01% | 2944 |
|
|
2020
Q3 | $594K | Buy |
4,966
+997
| +25% | +$119K | ﹤0.01% | 2829 |
|
|
2020
Q2 | $495K | Buy |
3,969
+2,611
| +192% | +$326K | ﹤0.01% | 2831 |
|
|
2020
Q1 | $262K | Buy |
1,358
+911
| +204% | +$176K | ﹤0.01% | 2929 |
|
|
2019
Q4 | $150K | Hold |
447
| – | – | ﹤0.01% | 3070 |
|
|
2019
Q3 | $145K | Sell |
447
-295
| -40% | -$95.7K | ﹤0.01% | 3075 |
|
|
2019
Q2 | $321K | Buy |
742
+174
| +31% | +$75.3K | ﹤0.01% | 2986 |
|
|
2019
Q1 | $322K | Buy |
568
+35
| +7% | +$19.8K | ﹤0.01% | 2923 |
|
|
2018
Q4 | $158K | Sell |
533
-9
| -2% | -$2.67K | ﹤0.01% | 3044 |
|
|
2018
Q3 | $385K | Buy |
542
+197
| +57% | +$140K | ﹤0.01% | 2921 |
|
|
2018
Q2 | $202K | Sell |
345
-56
| -14% | -$32.8K | ﹤0.01% | 3059 |
|
|
2018
Q1 | $1.08M | Buy |
+401
| New | +$1.08M | ﹤0.01% | 2490 |
|